Skip Navigation


Human Reproduction Update Advance Access originally published online on June 10, 2004
Human Reproduction Update 2004 10(4):341-348; doi:10.1093/humupd/dmh027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/4/341    most recent
dmh027v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gemzell-Danielsson, K.
Right arrow Articles by Marions, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gemzell-Danielsson, K.
Right arrow Articles by Marions, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update Vol. 10 No. 4 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception

K. Gemzell-Danielsson1 and L. Marions

Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital/Institute, S-171 76 Stockholm, Sweden

1 To whom correspondence should be addressed. Email: kristina.gemzell{at}kbh.ki.se

An emergency contraceptive method is used after coitus but before pregnancy occurs. The use of emergency contraception is largely under-utilized worldwide. One of the main barriers to widespread use is concern about the mechanism of action. Recently, treatment with either 10 mg mifepristone or 1.5 mg of levonorgestrel has emerged as the most effective hormonal method for emergency contraception with very low side-effects. However, the knowledge of the mechanism of action of mifepristone and levonorgestrel in humans, when used for contraceptive purposes and especially for emergency contraception, remains incomplete. The objective of this review is to summarize available data on the effects of mifepristone and levonorgestrel on female reproductive functions relevant to the emergency use of the compounds. When summarized, available data from studies in humans indicate that the contraceptive effects of both levonorgestrel and mifepristone, when used in single low doses for emergency contraception, involve either blockade or delay of ovulation, due to either prevention or delay of the LH surge, rather than to inhibition of implantation.

Key words: emergency contraception / endometrium / levonorgestrel / mifepristone / ovulation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
M. Engman, S. Granberg, A.R.W. Williams, C.X. Meng, P.G.L. Lalitkumar, and K. Gemzell-Danielsson
Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial
Hum. Reprod., August 1, 2009; 24(8): 1870 - 1879.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C.-X. Meng, K. Gemzell-Danielsson, O. Stephansson, J.-Z. Kang, Q.-F. Chen, and L.-N. Cheng
Emergency contraceptive use among 5677 women seeking abortion in Shanghai, China
Hum. Reprod., July 1, 2009; 24(7): 1612 - 1618.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
E. Estebanez-Perpina, L. A. Arnold, N. Jouravel, M. Togashi, J. Blethrow, E. Mar, P. Nguyen, K. J. Phillips, J. D. Baxter, P. Webb, et al.
Structural Insight into the Mode of Action of a Direct Inhibitor of Coregulator Binding to the Thyroid Hormone Receptor
Mol. Endocrinol., December 1, 2007; 21(12): 2919 - 2928.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P.G.L. Lalitkumar, S. Lalitkumar, C.X. Meng, A. Stavreus-Evers, F. Hambiliki, U. Bentin-Ley, and K. Gemzell-Danielsson
Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model
Hum. Reprod., November 1, 2007; 22(11): 3031 - 3037.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. A.A. do Nascimento, M. Seppala, A. Perdigao, X. Espejo-Arce, M. J. Munuce, L. Hautala, R. Koistinen, L. Andrade, and L. Bahamondes
In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration
Hum. Reprod., August 1, 2007; 22(8): 2190 - 2195.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
F. Davidoff and J. Trussell
Plan B and the politics of doubt.
JAMA, October 11, 2006; 296(14): 1775 - 1778.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
K. D. Karpa
Pharmacist Critique Was Ill-Informed
Ann. Pharmacother., July 1, 2006; 40(7): 1441 - 1444.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.